Introduction
Vestibular schwannomas (VSs) are rare slow-growing benign neoplasms of the cerebellopontine angle (CPA) and the internal auditory canal (IAC). They originate from the Schwann cells of the vestibular portion of the eighth cranial nerve. 1 The annual incidence is calculated to be 2 per 100,000. 2 Due to increased availability of modern diagnostic tools (auditory brainstem response [ABR] , magnetic resonance imaging [MRI] ), the number of incidental findings has consistently risen. 2, 3 The diagnosis is usually based on the combination of typical clinical symptoms and imaging findings. Early detection of VS allows the patient to benefit from modern and improved management strategies. Today patients can choose among microsurgery, radiotherapy, and wait-and-scan protocols. Fortunately, malignancy is scarce and more often associated with typical radiological findings so that nonsurgical procedures without histology are possible. Nevertheless, only surgery provides the ability of histopathological examination of tumor tissue to confirm the final diagnosis.
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Materials and Methods

Patient Data
Out of a series of 207 consecutive patients treated in our department between December 2005 and January 2015 for suspected VS, 198 histologic specimens were available for further examination. In the missing cases, no material was sent to the pathology department or sections were actually not available for further review. We extracted patient data from the records and reviewed preoperative imaging. There were 97 male and 101 female subjects aged 19 to 78 years (mean 52). All patients had undergone microsurgery via the middle cranial fossa (MCF) approach. Tumor stages were T1 (intracanalicular) in 82 cases and T2 (extrameatal part without contact to the brain stem) in 116 patients. We compared the 5 cases of non-VS to the 193 confirmed VS cases and tried to analyze the differences in preoperative findings.
Histopathology
All tissue specimens were routinely stained with hematoxylin and eosin (HE). Complementary immunohistochemistry usually includes S-100 and Ki-67 to confirm VSs as well as epithelial membrane antigen (EMA) to prove or exclude meningiomas. In some cases, we also used vimentin, pancytokeratin, CD56, EvG, actin, desmin, Ladewig, Kluver-Barrera, and periodic acid-schiff (PAS).
Imaging
In all cases, imaging was discussed in an interdisciplinary skull-base conference with a neuroradiologist prior to decision making. All tumors were suspected to be VS. The imaging of the non-VS cases was additionally analyzed by two different neuroradiologists.
Tumor size was measured in three spatial dimensions with the tumor length defined as the largest diameter across the whole tumor including the IAC. Tumor volume was calculated as a triaxial ellipsoid.
Compliance to Ethical Standards
The study was approved by the local ethics committee.
Results
Final Histologic Findings
In 193 tumors, histopathology confirmed the diagnosis of a VS. Five non-VS cases were diagnosed as three cases of meningioma (►Fig. 1a) and two cases of lipochoristoma (►Fig. 1b, c). The VS patients complained of hearing loss for an average of 26 months (n ¼ 125 patients), tinnitus for 25 months (n ¼ 107 patients), and dizziness for 14 months (n ¼ 90 patients) before surgery. In the non-VS group, three patients complained of hearing loss for 19 months, one patient suffered from tinnitus for 36 months, and three patients had dizziness for 13 months. In both groups, there were no cases of preoperative facial nerve symptoms. We could not find any differences between the five non-VS patients compared with the 193 VS patients in audiological testing (pure tone audiometry, speech discrimination test, AAO-HNS grade, ABR) or in facial nerve function (HouseBrackman score).
Preoperative Clinical Findings
Analysis of Preoperative Imaging
Two independent neuroradiologists reviewed all available preoperative images. The first meningioma patient had presented with three previous external MRIs. The fourth MRI was done with 1.5 Tesla in our neuroradiology department in 2004, but at that time, only film copies were archived. We found a typical tumor with extrameatal extent and strong dental artifacts. We were not able to distinguish between VS and meningioma with the films of that of last MR. All images of this patient had been discussed in four skull-base conferences and were diagnosed to be a VS. The second meningioma patient (►Fig. 2) presented with two consecutive external MR images within 6 months that showed a growing tumor. T1 images with contrast enhancement (T1CE) demonstrated a tumor without dural tail. The temporal bone computed tomography (CT) did not show any calcification of the lesion and no hyperostosis or hyperostotic spurs were visible. The third meningioma patient (►Fig. 3) also presented with typical signs of an intra-and extrameatal VS on the external MRI. T1CE images showed no dural tail, and CT scans did not detect calcification or bone alterations as previously described.
The first patient with a lipochoristoma (►Fig. 4) had received two external MR scans within 6 months, which were also demonstrated as being typical for VS. Retrospective analysis showed that the T1 images without contrast were too thick (5 mm) and only axial planes were available. The small intrameatal tumor was clearly visible on the T1CE images with fat saturation.
The second patient with a lipochoristoma (►Fig. 5) also had thick T1 precontrast and T2 slices (6 mm) in external imaging. The T1CE slices showed a small-enhanced intracanalicular tumor. This tumor was also still bright on T1CE images with fat saturation.
Intraoperative Findings
According to the surgeons report, there were no abnormalities during surgery in three of the non-VS cases. In one lipochoristoma and in one meningioma, extensive adherence of the tumor to the surrounding neurovascular tissue was described.
Discussion
In this series of 198 histologic results of small tumors of the CPA, five specimens (2.5%) were found not to be a VS as suspected preoperatively. Neoplasms of the CPA account for $8 to 10% of all intracranial tumors. Most tumors (81-91%) of the CPA are VS. [4] [5] [6] [7] Small tumors of the IAC typically present with hearing loss, tinnitus, and dizziness, 8,9 which were also the leading complaints in our 193 confirmed VS patients for an average period of 12 to 23 months prior to surgery. On MRI, VSs typically show T1 isointensity and T2 high signal intensity with strong enhancement after gadolinium injection. On heavily T2-weighted images, they replace the fluid signal of CSF. In CT scans, VSs are isodense or slightly hypodense and may present a widening of the IAC.
Histopathology of VSs usually shows two distinct patterns in HE staining: Antoni A and B. Additional immunohistochemistry to confirm the diagnosis shows a low proliferation index of Ki-67 and a strong expression of S-100.
Meningioma Cases (n ¼ 3)
Meningiomas comprise 15 to 20% of all intracranial neoplasms. They typically occur parasagittal/falcine and only in rare cases in the CPA. 10 Nevertheless, meningiomas represent 3 to 12% of the CPA cases and are known to be the second most nonschwannoma tumor in the CPA. 4, 5, 7, 11 All of our meningiomas consisted of an intra-as well as an extrameatal part (stage T2). Meningiomas limited to the IAC are rare. Bohrer and Chole 12 presented one intra-and one intra/ extrameatal meningioma and extracted four more purely intracanalicular cases from the literature prior to 1996. Unlike Mallucci et al, 13 who stated that patients with meningiomas presented with different symptoms compared with VS patients, we found hearing loss in two of the three cases and dizziness in all three cases. This can easily be explained by the close vicinity of the tumors to the vestibulocochlear nerve in the IAC. Meningiomas are, similar to VSs, isointense on T1 MRI with strong enhancement after gadolinium injection, but differ with isointensity on T2-weighted MR images. They can typically show increased thickness of the dura, presenting as a dural tail (so-called meningeal tail sign), which was not present in our three cases. Typical calcifications in CT scans are found in 20 to 50% of the meningiomas. Hyperostosis of the adjacent bone or a hyperostotic spur is possible as well, but none of these signs was visible in our three cases. This difficulty in distinguishing between VS and meningioma has also been described in a case report by Grauvogel et al in 2010, 14 in which they demonstrated that preoperative imaging could not differentiate that a tumor was a coexistence of a VS and a meningioma. Histopathological appearance of meningiomas can be variable. Within the group of benign meningiomas (WHO class I), there are even nine different subtypes described. If complementary immunohistochemistry shows no expression of S-100 but a strong expression of EMA, a meningioma can be diagnosed.
Lipochoristoma Cases (n ¼ 2)
Lipomatous tumors of the IAC are very rare CPA tumors (<<1%) 5, 15, 16 and it is considered that they are congenital malformations. 16 Recent literature has found the term lipochoristoma to be more accurate than lipoma because these tumors consist of adipose cells between nerve fibers mixed up with fibrous tissue.
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On MRI, lipochoristomas usually present isointense to fat with high signal on T1 and intermediate signal on T2. They do not enhance gadolinium and usually show a signal loss on fatsuppressed images. There are several case reports of IAC lipochoristomas. In most cases, fat saturation sequences led to the correct diagnosis and conservative treatment was offered. 15, 17, 18 In both of our lipochoristoma cases, only thick T1 slices were available and the tumor was classified to be isointense. We might have identified them to be hyperintense, if T1 thin slice images would have been available. Since both tumors in our series showed an uptake of contrast and were still visible in fat suppression, they were misdiagnosed as a VS. Bacciu et al 19 also reported on an uptake of contrast agent in four of eight lipomas of the CPA which led to the misdiagnosis of VS. The uptake of contrast agent and a persisting signal in fat suppression is not typical for lipomas (that typically solely consist of adipocytes), but it may be explained by the varied proportions of fat in relation to the surrounding nerve fibers in our lipochoristoma cases. 
Magnetic Resonance Imaging Recommendations
It is necessary to follow a standardized solid MRI protocol in diagnostics of the CPA. However, even in the "best" imaging series, we cannot always distinguish between VS and other lesions. There is no general recommendation, but we chose to use the specifications in ►Table 2 following the example of De Foer et al. 23 In ►Table 3, we summarize the typical characteristics of IAC tumors in MR diagnostics.
Limitations of the Study
Of course, this is only a retrospective analysis of preoperative imaging. As we operated on small VS in early stages, in some cases, more follow-up imaging may have led to another diagnosis. The study clearly shows that it may have been helpful to be more accurate with "inadequate" external MRI.
Of course, the knowledge of the final histology would have changed the therapy in the lipochoristomas toward observation.
Conclusion
Small lesions in the CPA and the IAC other than VSs are unusual but have to be taken into account. This should at least be kept in mind, especially in cases of radiotherapy or observation without proof of histology. In very small tumors, imaging still remains difficult. This is why patients should be provided with very detailed instructions as to what is expected from external imaging, or you should consider new imaging from "your" neuroradiologist experienced in skull base lesions.
